Full Press Release Details
• Announcements
• Price Sensitive
• June 20, 2024
Loading Viewer…
More Announcements & Updates
• Announcements
• July 31, 2024
• Announcements
• April 22, 2024
• Announcements
• December 17, 2021
• Announcements
• June 1, 2022
Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)
Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026
Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs
CLINICAL UPDATE AND CAPITAL RAISING OCTOBER 20th, 2025
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)
Dr. Oliver Sartor Appointed to Radiopharm Scientific Advisory Board
• RAD Presentation June 2026
• Zacks Small-Cap Research 2026
• RAD Presentation March 2026
• Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)
• Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026
• Zacks Small-Cap Research